Prime Medicine, Inc. (PRME)

Prime Medicine, Inc. (PRME) is a healthcare company (biotechnology) based in the United States. The share price is $4.10, down 2.15% on the day, which values the company at $914.27M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$4.10−2.15% today
Market value
$914.27M
200-week average
$6.0933% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Prime Medicine, Inc. in more detail

PRME trades at -5.0× next year's expected earnings, 129.5× sales. It sits 33% below its 200-week average of $6.09.

Over the last five fiscal years Prime Medicine, Inc. has compounded revenue -2.3% a year.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

2 of the superinvestors tracked here hold PRME, including Cathie Wood (0.2% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding PRME

2 of the investors tracked here report a position in their latest 13F filing.

Prime Medicine, Inc. (PRME): questions and answers

What is Prime Medicine, Inc.'s market cap?

Prime Medicine, Inc. is valued at $914.27M at a share price of $4.10.

Is PRME above its 200-week moving average?

No. PRME is 32.7% below its 200-week average of $6.09. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Prime Medicine, Inc. growing?

Over the last five fiscal years Prime Medicine, Inc.'s revenue grew -2.3% a year.

Does PRME pay a dividend?

Prime Medicine, Inc. does not currently pay a regular dividend.

Which famous investors own PRME?

In their latest quarterly filings, Cathie Wood (0.2% of the portfolio), Andrew Spokes (0.0% of the portfolio) hold PRME. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Prime Medicine, Inc. (PRME) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PRME

Underlying data: Yahoo Finance; company filings with the SEC.